UnitedHealth Group, Hims & Hers Health, and Eli Lilly and Company are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies operating within the healthcare sector—this includes pharmaceutical and biotechnology firms, medical device manufacturers, and providers of hospital and clinical services. They offer investors exposure to advances in drug development, medical technology, and healthcare delivery. Because their performance hinges on factors like regulatory approvals, patent expirations and reimbursement policies, they can carry distinct risks and rewards compared with broader market equities. These companies had the highest dollar trading volume of any Medical stocks within the last several days.
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
UNH traded up $8.48 during trading hours on Monday, hitting $408.40. The company's stock had a trading volume of 4,105,302 shares, compared to its average volume of 4,610,122. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The business's 50-day moving average price is $495.85 and its 200-day moving average price is $528.18. The stock has a market cap of $371.73 billion, a price-to-earnings ratio of 26.36, a P/E/G ratio of 1.37 and a beta of 0.61. UnitedHealth Group has a 12 month low of $393.11 and a 12 month high of $630.73.
Read Our Latest Research Report on UNH
Hims & Hers Health (HIMS)
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Shares of NYSE HIMS traded up $0.65 during mid-day trading on Monday, reaching $41.47. The company had a trading volume of 31,638,108 shares, compared to its average volume of 16,883,228. The business's 50-day moving average is $32.21 and its 200-day moving average is $31.56. The stock has a market cap of $9.21 billion, a price-to-earnings ratio of 92.97 and a beta of 1.84. Hims & Hers Health has a 52 week low of $11.45 and a 52 week high of $72.98.
Read Our Latest Research Report on HIMS
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
Shares of LLY traded down $1.60 during mid-day trading on Monday, hitting $822.02. 1,503,176 shares of the company traded hands, compared to its average volume of 3,470,179. The business has a 50 day moving average of $825.36 and a 200 day moving average of $814.96. Eli Lilly and Company has a 1-year low of $677.09 and a 1-year high of $972.53. The company has a quick ratio of 0.97, a current ratio of 1.15 and a debt-to-equity ratio of 2.00. The company has a market capitalization of $779.41 billion, a PE ratio of 70.02, a price-to-earnings-growth ratio of 1.40 and a beta of 0.51.
Read Our Latest Research Report on LLY
Featured Articles
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
